Literature DB >> 15623425

MK2-/- gene knockout mouse hearts carry anti-apoptotic signal and are resistant to ischemia reperfusion injury.

Keisuke Shiroto1, Hajime Otani, Fumio Yamamoto, Chi-Kuang Huang, Nilanjana Maulik, Dipak K Das.   

Abstract

Stress-induced mitogen-activated protein (MAP) kinases have been implicated in various forms of cardiovascular diseases. Ischemia/reperfusion potentiates activation of p38 MAP kinase (p38MAPK) leading to the activation of its downstream target MAPKAP kinase 2 (MK2). While p38MAPK has been shown to induce pro-apoptotic signal, whether MK2 also generates death signal is not known. To determine if MK2 triggers death signal, the hearts of MK2-/- knockout mice and genetically matched wild-type mice were subjected to 30 min ischemia followed by 2 h of reperfusion via Langendorff mode. The results indicated that the hearts of MK2-/- mice were resistant to myocardial ischemic reperfusion injury as evidenced by enhance recovery of post-ischemic ventricular performance, reduced myocardial infarct size and diminished number of apoptotic cardiomyocytes. We conclude that MK2, similar to p38MAPK, is involved in transmitting the death signal to the ischemic myocardium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15623425     DOI: 10.1016/j.yjmcc.2004.10.018

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  21 in total

1.  Mitogen-activated protein kinase-activated protein kinase 2 mediates apoptosis during lung vascular permeability by regulating movement of cleaved caspase 3.

Authors:  Mahendra Damarla; Ahmad R Parniani; Laura Johnston; Hasina Maredia; Leonid Serebreni; Omar Hamdan; Venkataramana K Sidhaye; Larissa A Shimoda; Allen C Myers; Michael T Crow; Eric P Schmidt; Carolyn E Machamer; Matthias Gaestel; Madhavi J Rane; Todd M Kolb; Bo S Kim; Rachel L Damico; Paul M Hassoun
Journal:  Am J Respir Cell Mol Biol       Date:  2014-05       Impact factor: 6.914

2.  Hsp70 Interacts with Mitogen-Activated Protein Kinase (MAPK)-Activated Protein Kinase 2 To Regulate p38MAPK Stability and Myoblast Differentiation during Skeletal Muscle Regeneration.

Authors:  Wei Fan; Xiu Kui Gao; Xi Sheng Rao; Yin Pu Shi; Xiao Ceng Liu; Fei Ya Wang; Yu Fen Liu; Xiao Xia Cong; Min Yi He; Shui Bo Xu; Wei Liang Shen; Yue Shen; Shi Gui Yan; Yan Luo; Boon Chuan Low; Hongwei Ouyang; Zhang Bao; Li Ling Zheng; Yi Ting Zhou
Journal:  Mol Cell Biol       Date:  2018-11-28       Impact factor: 4.272

3.  MMI-0100 inhibits cardiac fibrosis in myocardial infarction by direct actions on cardiomyocytes and fibroblasts via MK2 inhibition.

Authors:  Lei Xu; Cecelia C Yates; Pamela Lockyer; Liang Xie; Ariana Bevilacqua; Jun He; Cynthia Lander; Cam Patterson; Monte Willis
Journal:  J Mol Cell Cardiol       Date:  2014-10-01       Impact factor: 5.000

4.  Generation of survival signal by differential interaction of p38MAPKalpha and p38MAPKbeta with caveolin-1 and caveolin-3 in the adapted heart.

Authors:  Manika Das; Jianhua Cui; Dipak K Das
Journal:  J Mol Cell Cardiol       Date:  2006-10-25       Impact factor: 5.000

Review 5.  Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives.

Authors:  Sabzali Javadov; Sehwan Jang; Bryan Agostini
Journal:  Pharmacol Ther       Date:  2014-06-09       Impact factor: 12.310

6.  MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.

Authors:  John M Streicher; Shuxun Ren; Harvey Herschman; Yibin Wang
Journal:  Circ Res       Date:  2010-03-25       Impact factor: 17.367

Review 7.  Ras family small GTPase-mediated neuroprotective signaling in stroke.

Authors:  Geng-Xian Shi; Douglas A Andres; Weikang Cai
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2011-06-01

8.  MAPKAPK-2 modulates p38-MAPK localization and small heat shock protein phosphorylation but does not mediate the injury associated with p38-MAPK activation during myocardial ischemia.

Authors:  Diana A Gorog; Rita I Jabr; Masaya Tanno; Negin Sarafraz; James E Clark; Simon G Fisher; Xou Bin Cao; Mohamed Bellahcene; Kushal Dighe; Alamgir M N Kabir; Roy A Quinlan; Kanefusa Kato; Matthias Gaestel; Michael S Marber; Richard J Heads
Journal:  Cell Stress Chaperones       Date:  2009-02-13       Impact factor: 3.667

9.  Improvement of canine islet yield by donor pancreas infusion with a p38MAPK inhibitor.

Authors:  Taihei Ito; Keiko Omori; Jeffrey Rawson; Ivan Todorov; Sadaki Asari; Akio Kuroda; Jonathan Shintaku; Shin Itakura; Kevin Ferreri; Fouad Kandeel; Yoko Mullen
Journal:  Transplantation       Date:  2008-07-27       Impact factor: 4.939

10.  Nebulized Delivery of the MAPKAP Kinase 2 Peptide Inhibitor MMI-0100 Protects Against Ischemia-Induced Systolic Dysfunction.

Authors:  David I Brown; Brian C Cooley; Megan T Quintana; Cynthia Lander; Monte S Willis
Journal:  Int J Pept Res Ther       Date:  2016-01-09       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.